Archive

July 7, 2026

Browsing

Artificial intelligence adoption accelerated sharply across enterprises in 2026, but soaring usage costs are prompting many businesses to rethink their technology choices.

This has driven growing interest in Chinese-developed AI models that offer comparable capabilities at a fraction of the price.

As companies expand AI deployments across software development, customer service and workflow automation, many are discovering that usage-based pricing has made AI bills far more unpredictable than initially expected.

While the price of individual AI tokens has generally declined, the overall cost of completing increasingly complex tasks has risen as AI providers move away from flat subscription models toward consumption-based pricing.

The mounting costs are encouraging developers, startups and even larger enterprises to experiment with lower-cost open-source models, many of which originate in China.

Rising AI bills reshape buying decisions

The cost challenge has become increasingly visible across corporate America.

According to reports, Uber exhausted its entire 2026 artificial intelligence budget in just four months after employees rapidly adopted AI coding tools, forcing management to introduce usage limits.

The experience highlights a broader shift unfolding across enterprises, where organizations are now scrutinizing AI spending much more closely and increasingly routing less demanding tasks to lower-cost models instead of relying exclusively on premium offerings from US companies.

Chinese models have emerged as some of the biggest beneficiaries of that trend.

A Citi note said leading Chinese models now charge as little as 18 cents per million tokens compared with roughly $4 per million tokens for top US frontier models while continuing to narrow the capability gap.

On OpenRouter, a platform that allows developers to access multiple AI models through a single interface, the four most widely used models are now all Chinese, with DeepSeek remaining the most popular.

DeepSeek, which emerged as the face of China’s AI ambitions last year, continues to charge only about 3% of the token price of OpenAI’s GPT 5.5, making it one of the cheapest frontier models available.

Competition among Chinese developers has also intensified, with companies including Alibaba, Moonshot AI and Zhipu AI racing to improve performance and benchmark rankings.

Chinese models rapidly gain market share

The growing appeal of Chinese models is reflected in adoption data.

The share of tokens consumed by US companies through Chinese models on OpenRouter has remained above 30% every week since Feb. 8 and has climbed as high as 46%.

That represents a dramatic increase from an average of 11% over the previous 12 months and just 4.5% during the first half of 2025.

Z.ai’s GLM 5.2 is becoming especially popular

Among the newest entrants, Z.ai, or Zhipu AI’s GLM 5.2, has emerged as one of China’s strongest challengers.

According to Artificial Analysis’ benchmark rankings, GLM 5.2 ranks fifth globally behind three Anthropic models and one OpenAI model while outperforming Google’s Gemini models.

If enterprises use the version hosted by Zhipu in China, the token cost is only about 15% of that charged by OpenAI’s comparable model.

The model has been adopted rapidly since its June release.

Harpreet Arora, head of agentic infrastructure at Vercel, told CNBC that GLM 5.2 experienced the fastest adoption of any model tracked by the company during 2026.

“In its first full week after launch, daily token volume grew about 27x, and the number of customers using it grew about 80x.”

Arora said pricing has become the decisive factor for many developers.

“Price is doing the work here,” Arora said.

“When a task doesn’t need the best model, teams are beginning to route it to the cheapest one that’s good enough, and the recent wave of models coming out of China is winning that trade.”

GLM 5.2 is regarded as particularly effective for software development and AI agents capable of interacting with other applications autonomously.

According to a New York Times report, Rehaan Ahmad, co-founder of Silicon Valley startup alphaXiv, said the performance gap has narrowed considerably.

The model also incidentally came out when executives in Silicon Valley were becoming worried that the Trump administration was leaning toward regulating the technology.

“With Fable restricted, the gap between the US and China is very slim,” Ahmad said.

The report also cited ArenaAI Chief Executive Anastasios Angelopoulos, who said Z.ai has become the world’s third most widely used AI technology platform.

Last month, Bloomberg reported that Zhipu is considering a share sale to raise several billion US dollars in Hong Kong, people familiar with the matter said, after soaring about 2,000% since its listing in January.

Zhipu is working with advisers on a potential placement that may take place as soon as next month, the people said, asking not to be identified because the information is private. A six-month lock-up from its IPO expires on July 8.

Last month, Chinese AI startup Zhipu was weighing a multi-billion dollar share sale after it skyrocketed around 2,000% since its January IPO, Bloomberg reported, underscoring the enduring optimism around the country’s AI stocks.

Big cloud providers broaden access; smaller businesses gain most

Major US cloud providers are also making Chinese models easier to access.

Microsoft, Amazon Web Services and Google Cloud already offer models from DeepSeek, Z.ai, MiniMax and other Chinese developers through their cloud platforms.

According to people familiar with the matter cited by Axios, Microsoft has also explored adding DeepSeek’s latest model to power one of its own AI products, which currently relies on OpenAI and Anthropic technologies.

For startups, the economics are becoming increasingly difficult to ignore.

Rest of World reported that San Francisco-based AI startup Lindy recently switched from Anthropic’s models to DeepSeek.

Founder Flo Crivello said the move saved the company millions of dollars.

“You don’t need God to write your email,” Crivello said on technology show MTS.

“If you can get those lower tiers of intelligence for a tenth of the price, it would be foolish not to do it.”

The publication also cited Dallas developer Ruben Garcia Jr., who spends about $500 each month on Claude and ChatGPT for sophisticated planning while paying another $200 for Chinese models including Minimax, Moonshot’s Kimi and Xiaomi MiMo, which handle roughly 90% of routine coding and voice-recognition work.

Kyle Chan, a fellow at the Brookings Institution, told Rest of World that enterprise adoption among large companies is already relatively mature.

“[AI] adoption at large companies is fairly saturated,” Chan said. “The growth market for Chinese companies would be medium-sized businesses that are starting to get into AI but are wary of the costs.”

Security concerns remain a hurdle

Despite the growing momentum, analysts say geopolitical and security concerns remain major obstacles to widespread enterprise adoption.

Many organizations remain reluctant to process sensitive data through AI systems hosted in China because of concerns over government oversight, censorship and potential export-control risks.

Z.ai was added to the US Commerce Department’s trade blacklist in 2025, while corporate filings show several shareholders are linked to a Chinese government agency overseeing the country’s defense industry.

Companies using Chinese models have also attracted political scrutiny.

Lawmakers have investigated Airbnb and AI coding startup Anysphere after disclosures that they used Chinese open-source models including Qwen and Kimi.

Airbnb Chief Executive Brian Chesky later clarified that the company was not sending customer data to model developers.

Poe Zhao, founder of the Beijing-based newsletter Hello China Tech, told Rest of World that regulated industries would remain cautious because of concerns over data security and geopolitics.

However, GLM’s open-weight architecture allows companies to deploy the model on their own servers or private cloud infrastructure without sharing data with Zhipu.

Val Bercovici, chief AI officer at WEKA, told Reuters that open-source AI models are increasingly delivering the right balance between performance and cost.

“90% as good at 10% of the price,” he said. “We don’t need to spend the premium tokens on every level of effort.”

Still, the pricing advantage may not last indefinitely.

According to The Wall Street Journal, OpenAI is considering significant price cuts as competition with Anthropic and lower-cost Chinese rivals intensifies in the enterprise AI market.

The post Cheap, capable, and controversial: why US companies cannot resist Chinese AI models appeared first on Invezz

Palo Alto Networks stock continues its strong uptrend this week and is now hovering at its all-time high. PANW jumped by 156% from its lowest point this year, with analysts expecting more gains. 

BNP Paribas predicts that PANW will jump from the current $357 to $380, while Wells Fargo sees it soaring to $420. Other analysts who are bullish on the company are from BTIG and Arete Research. 

Palo Alto Networks stock faces technical stocks

The general view among analysts is that Palo Alto Networks will continue doing well in the coming years because of the AI boom. The theory is that, as AI agents become more common, companies will need defensive measures.

All these points are valid. However, technicals suggest that the stock may experience a brief retreat in the coming weeks or months. For one, the stock has become extremely overbought, with the Relative Strength Index (RSI) soaring to 80. Baring a minor retreat in June, it has remained in the overbought zone since May. 

Notably, the RSI indicator has formed a double-top pattern with a neckline at 57. This pattern suggests that it will reverse in the near term. 

At the same time, the current PANW stock has deviated substantially from its historical moving averages. The 50-day moving average is at $265, much lower than the stock’s price of $357. 

As such, there is a risk that the stock will go through a situation known as mean reversion. This is a situation where an asset drops back to its historical moving averages as investors book profits. 

Therefore, these technicals point to a short-term reversal, potentially to the psychological level of $300. Such a pullback will not be new for the stock. For example, after rising to $222.85 in October 25, the stock retreated by 37% to $139.1 in February and then bounced back. 

PANW stock chart | Source: TradingView

Palo Alto Network’s business is doing fairly well

Palo Alto Network’s business is expected to keep doing well in the coming years, especially now that it has acquired CyberArk. CyberArk gave it CORA AI, the central hub for identity security-focused AI capabilities. 

Yahoo Finance data shows that the average view is that its revenue will jump by 24% this year to $11.4 billion. It is expected to rise by 20% in the next financial year to nearly $14 billion. Similarly, its earnings per share are expected to hit $3.77.

Based on Palo Alto’s history, chances are that it will do better than what analysts expect. It has beaten forecasts in the past 7 consecutive quarters.

Still, in addition to its risky technicals, PANW stock’s other risk is its valuation. SeekingAlpha data shows that it has a forward price-to-earnings ratio of 92.25, higher than the sector median of 24. Its PE multiple is much higher than the five-year average of 57.

This valuation multiple suggests that the company is priced for perfection and that its next earnings report will be crucial. If the earnings and guidance are not all that strong, there is a risk that it may retreat as it did after the last earnings report when it fell to $250 from $305.

READ MORE: PANW stock dubbed ‘double table pounder’ despite muted outlook

The post Here’s the key risk facing the Palo Alto Networks stock today appeared first on Invezz

Crinetics Pharmaceuticals shares surged after Vertex Pharmaceuticals announced an agreement to acquire the endocrinology-focused biotech companyin a deal valued at approximately $10 billion.

The all-cash transaction values Crinetics at $85 per share and is expected to close during the current quarter, subject to customary conditions.

The acquisition sparked a sharp rally in CRNX stock.

CRNX shares climbed nearly 100% in pre-market trading on Tuesday to around $83.69.

Vertex shares, meanwhile, declined modestly following the announcement.

The transaction comes amid a wave of pharmaceutical industry acquisitions, as large drugmakers seek to strengthen their development pipelines by acquiring smaller biotechnology companies with promising therapies.

Vertex targets endocrinology growth

According to a joint press release, Vertex expects Crinetics’ portfolio, including its approved acromegaly treatment Palsonify and investigational therapy Atumelnant, to contribute an estimated $5 billion in peak annual sales.

Crinetics focuses on therapies for endocrine disorders.

The company markets Palsonify, a once-daily oral treatment approved by the US Food and Drug Administration in September for acromegaly, a rare hormonal disorder caused in most cases by a noncancerous pituitary gland tumour that leads to excessive growth hormone production during adulthood.

The disease can result in enlargement of the face, jaw, hands, and feet, along with symptoms including joint pain, headaches, and nausea.

Crinetics said Palsonify works by lowering insulin-like growth factor to help alleviate these symptoms.

The company’s pipeline also includes Atumelnant, a once-daily oral treatment under development for congenital adrenal hyperplasia (CAH), a group of inherited disorders affecting the adrenal glands.

The condition leads to excessive production of male sex hormones known as androgens.

Patients with CAH are commonly treated with high-dose glucocorticoids, which are associated with multiple side effects.

Crinetics is developing Atumelnant as an alternative treatment approach.

The company also said the therapy has demonstrated potential in treating Cushing’s syndrome, a rare hormonal disorder characterised by excessive cortisol levels that can cause rapid weight gain, muscle weakness, bruising and high blood pressure.

CEO highlights strategic fit

Vertex Chief Executive Officer Reshma Kewalramani described the acquisition as strategically aligned with the company’s long-term growth plans.

“Its focus on serious diseases in specialty markets with significant unmet need, well-understood causal human biology, and potentially best-in-class medicines could deliver transformative benefit to patients,” she said in a statement.

Kewalramani added that Vertex intends to build on its experience in rare genetic diseases to continue expanding the commercial potential of Palsonify.

Vertex has established its business around treatments for cystic fibrosis and has also expanded into gene-editing therapies through its partnership with CRISPR Therapeutics.

Premium reflects pipeline potential

Crinetics closed at slightly above $42 per share before the announcement, meaning Vertex’s offer represents a premium of more than 100%.

According to the companies, the acquired portfolio could generate approximately $5 billion in peak annual sales.

Vertex reported total revenue of $12 billion last year, making the acquisition a significant addition to its long-term growth strategy.

Market analysts also viewed the strategic rationale positively.

Citi analyst Geoff Meacham said the acquisition aligns well with Vertex’s existing strengths in specialty diseases and biologically targeted medicines.

“The fit is clear, given existing expertise in specialty markets, serious diseases, causal biology, and measurable biomarkers. The $5 billion peak sales framing adds another route to sustain double-digit topline growth.”

Meacham maintained a Buy rating on Vertex and set a price target of $585, indicating further upside from the stock’s previous closing level.

The post Crinetics shares surge after Vertex agrees to $10B cash buyout appeared first on Invezz

Dow Jones opened higher on Tuesday even as the Nasdaq came under pressure from another broad selloff in semiconductor stocks, highlighting a divergence in US equity markets ahead of the second-quarter earnings season.

The Dow Jones Industrial Average gained about 160 points, or 0.3%, while the Nasdaq Composite fell around 0.7%.

The S&P 500 slipped 0.25% as weakness in chipmakers weighed on the broader technology sector.

The mixed performance follows Monday’s session, when the Dow briefly crossed the 53,000 mark for the first time and closed above the milestone, while the S&P 500 and Nasdaq Composite posted solid gains led by a rebound in semiconductor stocks.

Dow outperforms as chip stocks pressure Nasdaq

The Dow’s relative strength contrasted with declines across major semiconductor names in trading.

Micron Technology fell about 6.9%, while KLA, Marvell Technology, Broadcom and Advanced Micro Devices also traded lower.

Nvidia lost more than 1.4% after a Reuters report said Chinese startup DeepSeek is developing its own artificial intelligence chip, a move that could reduce its reliance on chips from Nvidia and Samsung.

Memory stocks were among the biggest decliners.

Western Digital dropped more than 6%, while SanDisk also fell 8% as investors continued to take profits after the sector’s strong rally over the past year.

Dow was supported by gains in software companies including Microsoft, Salesforce and IBM, helping the blue-chip index outperform despite broader weakness in technology hardware stocks.

Meanwhile, SpaceX was set to join the Nasdaq-100 on Tuesday, with its shares trading modestly higher ahead of the index inclusion after the industry’s mandatory quiet period expired.

Samsung selloff weighs on global chip sector

The latest wave of selling began in Asia after South Korea’s Kospi index dropped nearly 5%, driven by heavy losses in semiconductor companies.

Samsung Electronics fell nearly 7% despite reporting a 19-fold increase in second-quarter operating profit.

Investors appeared to focus instead on concerns about spending, demand and elevated expectations following the stock’s strong rally.

SK Hynix also declined sharply, extending weakness across the memory-chip industry.

The company is scheduled to begin trading on the Nasdaq later this week, giving investors another closely watched event for the semiconductor sector.

The weakness spread into Europe, where the STOXX 600 index edged lower, before reaching US markets.

Analysts said the market reaction reflects heightened expectations heading into earnings season after semiconductor stocks led much of this year’s rally.

Earnings and Fed remain in focus

Investors are now turning their attention to the second-quarter earnings season, which is expected to test whether artificial intelligence-related companies can justify their elevated valuations.

Market participants are also awaiting minutes from the Federal Reserve’s latest policy meeting on Wednesday, the first under Chair Kevin Warsh.

According to LSEG data, traders currently expect at least one 25-basis-point interest rate increase before the end of the year.

Outside the technology sector, Fiserv rose after reports that the payments company had discussed selling its debit card payments infrastructure business to major US banks, including JPMorgan Chase and Bank of America.

Rivian shares fell more than 10% after the electric vehicle maker launched an offering of 75 million shares despite forecasting second-quarter revenue above analysts’ estimates.

Oil prices also moved higher following reports of attacks on vessels near the Strait of Hormuz, adding another factor for investors to monitor as markets head into a busy week of earnings and monetary policy updates.

The post Dow gains 160 points as chip selloff drags Nasdaq ahead of earnings season appeared first on Invezz

US stocks opened higher on Monday, with the S&P 500 and Nasdaq looking to extend last week’s rally.

Investors welcomed a rebound in semiconductor shares while preparing for the release of Federal Reserve meeting minutes and the start of the second-quarter earnings season later this week.

The Dow Jones Industrial Average gained 83 points as the blue-chip index closed at a record high before the Independence Day holiday, putting it within the reach of the 53,000 level for the first time.

The S&P 500 gained 0.48%, while the Nasdaq Composite advanced 0.87%.

The major indexes each gained around 2% last week, even as semiconductor stocks lost momentum.

Investors instead rotated into sectors such as healthcare, industrials and financials, supporting a broader market advance.

Chip stocks rebound after recent weakness

Technology shares led gains on Monday, with semiconductor and storage companies recovering after recent declines.

Broadcom rose 5.8% after the chipmaker and Apple agreed to expand their partnership through 2031 to develop and supply a range of custom chips.

Memory chipmakers also rallied, with Western Digital climbing 8.6%, Seagate advancing 5.7%, and Micron Technology gaining 1.7%.

The broader technology sector strengthened as well.

The Technology Select Sector SPDR ETF rose more than 1%, helped by a 5.22% gain in Teradyne, while Marvell Technology and Oracle rose more than 2.88% and 1.28%, respectively.

The rebound followed two consecutive weekly declines for the VanEck Semiconductor ETF, which fell 3.2% last week as investors trimmed exposure to chipmakers after their strong gains earlier this year.

Elsewhere, South Korean memory chipmaker SK Hynix is set to begin trading its US listing on Monday in a deal expected to raise about $28 billion.

SpaceX shares also edged 1.6% higher ahead of the company’s planned inclusion in the Nasdaq-100 on Tuesday.

Earnings season and Fed remain in focus

Investor attention is also turning toward the second-quarter earnings season, which begins to gather pace later this week.

Delta Air Lines and PepsiCo are among the companies scheduled to report results in the coming days.

According to LSEG data, S&P 500 companies are expected to post year-over-year earnings growth of 24.4% during the second quarter.

Markets are also awaiting the minutes from the Federal Reserve’s June meeting, the first chaired by Kevin Warsh, due for release on Wednesday.

Rate hike expectations eased following last week’s weaker-than-expected US jobs report.

According to CME FedWatch data, traders now see a 24% chance of a 25-basis-point rate increase at the Fed’s July meeting, down from about 30% a week earlier. Expectations for a September rate hike have also eased.

Fed Governor Christopher Waller is also scheduled to speak later on Monday, while investors will monitor the latest ISM services survey, which is expected to show only a modest easing in activity to a still-expansionary reading of 54.0.

Global markets mixed as investors assess outlook

Outside the United States, trading was more subdued.

Europe’s STOXX 600 slipped 0.5%, while Asia-Pacific markets finished mixed. Japan’s Nikkei 225 ended little changed and the broader Topix rose 0.92%. South Korea’s Kospi fell 0.46%, while the Kosdaq declined 2.46%.

Australia’s S&P/ASX 200 slipped 0.15%, China’s CSI 300 finished flat, and Hong Kong’s Hang Seng traded 0.81% higher.

The mixed global performance reflected cautious positioning as investors balanced expectations for corporate earnings, monetary policy and continued sector rotation following Wall Street’s strong performance last week.

The post Dow rises 80 points as chip stocks rebound ahead of Fed minutes, earnings season appeared first on Invezz

Sandisk stock price has suffered a harsh reversal recently as the recent bull run hits a wall. SNDK dropped by 14% on Friday, reaching its lowest level since June 11. It has now slumped by 25% this year, even as top Wall Street analysts have maintained their bullish outlook.

Top analysts are bullish on Sandisk stock

Sandisk stock has done well in the past 18 months, making it the best gainer in the S&P 500 Index. It jumped by 4,000% in the last 12 months, with its market capitalization crossing the $300 billion mark.

Despite these gains, analysts are highly bullish on the stock, with most of them hiking their forecasts. In a recent note, Bernstein hiked its target from $2,100 to $2,500, citing the strong demand for memory products after the robust Micron earnings.

Bank of America hiked its target from $1,700 to $3,400, noting that its multi-year contracts were helping it avoid the cyclical issues that have affected the industry in the past. With SNDK trading at $1,745, a surge to $3,000 implies a 71% jump. 

Citigroup has also hiked the target price from $2,025 to $2,500, while Cantor Fitzgerald boosted from $1,800 to $2,900. Other companies that have hiked their targets are Mizuho and Morgan Stanley.

Sandisk’s growth to continue but risks remain

There is a possibility that Sandisk’s revenue growth will accelerate in the coming months as memory prices rise. A recent report showed that DRAM and NAND contract prices rose by 18% and 15% in the second quarter, respectively. While this was a strong growth, it was lower than the 60% experienced in Q1.

Sandisk primarily sells memory equipment like SSDs, memory cards, and USB flash drives. Yet, the cooling DRAM and NAND prices mean that its business too may be affected.

Data shows that analysts are predicting that its revenue jumped by 335% in the last quarter to $8.29 billion. For the year, the revenue is expected to grow by 168% to $19 billion, followed by 141% to $47 billion. These are strong numbers for a company that was spun out by Western Digital last year.

READ MORE: Sandisk stock is firing on all cylinders: is a day of reckoning coming?

The risk, however, is that the soaring memory prices may lead to overproduction, which will affect the global supply. Historically, the memory industry has experienced such periods of strong growth followed by slumps.

On the positive side for Sandisk, its stock is not highly overvalued. Ideally, you would expect a high-margin company growing by triple digits to have high price-to-earnings multiples. In its case, it trades at a forward PE ratio of 26, slightly higher than S&P 500 Index’s 22.

The challenge for Sandisk is that any sign that memory prices are cooling will have a negative impact on its stock. 

Sandisk stock faces technical risks

SNDK stock chart | Source: TradingView

The other risk facing SNDK stock is that its technicals have worsened recently, a sign that it has moved to the distribution phase of the Wyckoff Theory. This phase is then followed by the markdown stage.

The stock’s Relative Strength Index (RSI) has formed a bearish divergence pattern, moving from a high of 81 to 46 today. It also remains much higher than the 100-day moving average, which is at $1,285.

The bearish divergence and a potential mean reversion may push it lower in the near term. On the other hand, a move above the key resistance at $2,360 will invalidate the bearish outlook.

The post Sandisk stock forms a bearish divergence, enters a risky Wyckoff phase appeared first on Invezz

Broadcom Inc. AVGO shares rose 5.3% in trading on Monday after the semiconductor company announced an extension of its long-standing partnership with Apple Inc. through 2031.

The agreement reinforces Broadcom’s position as one of the iPhone maker’s key chip suppliers.

The new multi-year agreement expands the companies’ collaboration on custom silicon products and provides Broadcom with long-term revenue visibility from one of its largest customers.

Apple accounts for about 20% of Broadcom’s annual revenue, according to analysts, making the partnership strategically important for the chipmaker.

Broadcom secures long-term Apple partnership

Broadcom said it has agreed to expand its partnership with Apple through 2031 to develop and supply custom chips, easing concerns over the iPhone maker’s reliance on the semiconductor company.

According to Broadcom’s recent SEC filing:

“Broadcom Inc. (“Broadcom”) and Apple Inc. (“Apple”) have agreed to expand their long-standing technology collaboration through 2031 by entering into new multi-year long-term agreements for Broadcom to develop and supply a range of custom ASIC silicon products for use in multiple generations of Apple products.”

The agreement covers a range of custom silicon products that will be used across multiple generations of Apple devices.

Financial terms of the extension were not disclosed.

Broadcom has supplied Apple with key components for years, including radio frequency chips that enable iPhones to connect to cellular networks, Wi-Fi and Bluetooth connectivity chips, and other networking semiconductors.

Although Apple has developed several in-house chips, including its C1 modem, it continues to rely on Broadcom for wireless and radio-frequency components.

The companies had previously announced a multibillion-dollar agreement in 2023 for Broadcom to develop and manufacture 5G radio frequency components.

The latest extension builds on that relationship and secures Broadcom’s role in Apple’s supply chain through the end of the decade.

Apple navigates chip supply challenges

The extended partnership aligns with Apple’s strategy of securing long-term supply agreements with key semiconductor companies to strengthen the resilience of its supply chain.

Apple relies on Taiwan’s TSMC, the world’s largest contract chipmaker, to manufacture its in-house processors, including the M-series chips used in Mac computers and the A-series processors that power iPhones.

Demand for advanced chips has intensified as artificial intelligence adoption accelerates.

The growth of AI inference—the process by which models respond to user queries—has increased demand for custom chips and advanced processors, creating greater competition for manufacturing capacity.

TSMC has faced heavy demand from AI chipmakers such as Nvidia. Apple Chief Executive Tim Cook said in April that these capacity constraints had affected iPhone sales.

Apple is also in discussions with Intel to manufacture some chips in the United States, although analysts have said volume production is unlikely before late 2027.

AI demand drives semiconductor market

The broader semiconductor industry has experienced rising component costs as AI infrastructure spending continues to expand.

Prices for memory and storage chips have climbed sharply in recent months, driven by increasing demand from AI hyperscalers.

Apple raised prices for its MacBooks and iPads in June after memory chip costs surged as much as 98% during the first half of 2026.

Beyond its relationship with Apple, Broadcom has been expanding its presence in the artificial intelligence market by developing AI-specific chips for other major technology companies, including Alphabet and Meta Platforms.

The post Broadcom extends Apple chip partnership through 2031, stock climbs 5% appeared first on Invezz

Oracle Corp. (ORCL) shares gained 1.3% on Monday as investors returned to the stock following a sharp, debt-driven sell-off, amid improving broader market sentiment.

The recovery also came as broader market sentiment improved, with the Nasdaq Composite gaining 0.95% and the S&P 500 advancing 0.44%.

The move marked a shift in investor sentiment after weeks of selling pressure driven by concerns over Oracle’s aggressive investments in artificial intelligence (AI) infrastructure.

While questions remain over the company’s capital spending plans and debt levels, some investors now appear to believe the earlier decline had become excessive.

Backlog supports long-term growth outlook

Oracle has faced significant selling pressure in recent weeks.

The stock has declined 28.03% so far this year as investors have questioned the sustainability of its debt-funded AI expansion.

Investor concerns centred on the company’s negative free cash flow and its plans to raise as much as $40 billion in financing to support continued investment in AI infrastructure.

Despite these concerns, Oracle’s remaining performance obligation (RPO) backlog of $638 billion continues to provide long-term revenue visibility.

The sizeable backlog has reinforced confidence among some investors that the company’s heavy AI investments could translate into future growth.

The strength of the backlog has become one of the key factors supporting the stock’s recovery after the recent correction.

AI investment triggered a historic sell-off

Oracle’s rebound follows one of the sharpest monthly declines in the company’s history.

The stock fell about 35% in June after gaining nearly 40% in May.

The June decline marked Oracle’s worst monthly performance since September 1990.

The sell-off followed reports that Oracle spent $16.5 billion on capital expenditures during its latest quarter as it expanded its AI infrastructure.

The spending pushed the company’s full-year free cash flow to negative $23.7 billion, intensifying investor concerns about the pace and scale of its investment strategy.

Market expectations suggest that Oracle’s capital expenditure could rise to approximately $92 billion in the next fiscal year.

At the end of May, the company’s debt stood at around $130 billion.

These figures prompted investors to question whether Oracle’s expansion plans would place additional pressure on its balance sheet in the near term.

Analysts remain constructive despite debt concerns

Although concerns over debt and capital spending weighed heavily on the stock, several analysts maintained bullish ratings on Oracle during June.

They also raised their price targets, citing continued strength in cloud computing and AI demand.

The positive analyst outlook has provided additional support for investors who believe the recent decline may have been overdone.

Historical trading patterns also suggest that Oracle has often recovered after experiencing steep monthly declines.

Since 1986, Oracle has recorded monthly declines of 30% or more only eight times.

Following the previous seven instances, the stock typically rebounded, delivering a median gain of 16% over the following three months and 93% over the subsequent year.

The stock finished higher roughly two-thirds of the time after those previous declines.

Monday’s gain suggests that investors are once again focusing on Oracle’s long-term growth prospects, even as questions surrounding debt levels, free cash flow, and future capital expenditure continue to remain in focus.

The post Oracle shares rose as investors reassess AI-driven sell-off appeared first on Invezz

Tesla stock (TSLA) rose on Monday, recovering some of last week’s sharp losses after investors sold the stock despite a stronger-than-expected second-quarter delivery report.

The rebound came as the electric-vehicle maker expanded its robotaxi service to Miami, adding another city to its autonomous ride-hailing network.

Shares of Tesla climbed about 3% to $405.11 in early trading.

The move was also supported by broader market optimism, with the S&P 500 up 0.6% and the Nasdaq climbing around 1%.

Miami robotaxi launch marks latest expansion

The stock gained after Tesla announced that its robotaxi service became available in Miami from July 3, extending the company’s autonomous ride-hailing footprint beyond Texas.

The expansion makes Florida the third state where Tesla’s robotaxi operations are available.

The company launched its robotaxi service in Austin about a year ago and has since expanded to additional Texas cities. Tesla also operates a rideshare service in San Francisco.

The rollout forms part of Chief Executive Officer Elon Musk’s broader strategy to position artificial intelligence, autonomous driving, and robotics as Tesla’s next major growth engines.

Investors have closely watched the pace of Tesla’s robotaxi expansion, although the rollout has remained gradual as the company prioritizes safety.

Tesla has said it does not expect robotaxis to become a meaningful contributor to revenue and earnings until at least 2027.

Delivery beat improves investor sentiment

Sentiment has also improved following Tesla’s second-quarter delivery report, which exceeded Wall Street expectations.

Tesla reported 480,126 global vehicle deliveries during the quarter, representing a 25% increase from a year earlier.

The company also reported that energy deployments rose 41%, extending the momentum of a business that has grown rapidly even as vehicle demand has fluctuated.

The second-quarter performance followed a 6.3% year-over-year increase in deliveries during the first quarter.

Gary Black, managing director of The Future Fund, said in a post on X that he expects Tesla shares to recover further as analysts revise their earnings forecasts.

“I expect TSLA stock to rebound this week as the sell-side climbs over one another to increase 2Q and FY’26 earnings ests,” Black said, adding that higher earnings projections “could boost TSLA price targets.”

Black nevertheless argued that Tesla’s valuation remains demanding.

He said the stock trades at a 2026 price-to-earnings multiple of more than 200 times despite expected long-term earnings-per-share growth of roughly 35% between 2027 and 2032.

According to Black, that “continues to suggest TSLA is fully priced.”

He also suggested that higher gasoline prices during the quarter may have contributed more to stronger vehicle demand than growing enthusiasm around autonomous driving.

Analysts maintain constructive outlook

Morgan Stanley analyst Andrew Percoco said Tesla’s second-quarter deliveries exceeded sell-side consensus estimates by 18% and represented the company’s strongest vehicle growth since the third quarter of 2023.

The firm maintained its Equal Weight rating and a $415 price target.

Separately, Baird reiterated its Outperform rating and $522 price target after Tesla’s second-quarter results surpassed both the firm’s own forecasts and broader consensus expectations.

Baird also highlighted Tesla’s energy storage business, noting that deployments reached 13.5 gigawatt-hours during the quarter, up approximately 41% year over year.

While acknowledging that energy deployments can be uneven from quarter to quarter, the firm described the results as a positive development and said its constructive outlook on Tesla remains unchanged.

Tesla is scheduled to report its full second-quarter financial results after the market closes on July 22.

The post Tesla stock up 3% today after Thursday's selloff: what's behind the rebound? appeared first on Invezz